NYSE:JNJPharmaceuticals
Is It Time To Reassess Johnson & Johnson (JNJ) After Its Strong 1 Year Share Price Run?
If you are asking whether Johnson & Johnson at around US$227.79 is still a reasonable entry or more of a hold for now, you will want to look closely at what the current valuation is really telling you.
Over the last year the stock has recorded a 50.2% return, with a 9.9% return year to date, alongside a 0.7% move over the past week and a 5.3% decline across the last month, which together give you a mixed picture of recent sentiment.
Recent headlines around Johnson & Johnson have focused on...